News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Another Warning for CareFusion Corporation's Alaris Infusion Pumps



11/16/2012 8:27:54 AM

Certain of CareFusion's Alaris infusion systems, a product line already affected by recalls, are the subject of another warning over potential air bubbles that may be transferred to the patient. CareFusion (NYSE:CFN) issued a new warning over potential issues with its Alaris infusion pumps, a product line already targeted by 2 recalls. The San Diego-based device maker warned clinics that its Alaris GP Infusion pumps produce air bubbles that are too small to trigger the device's detection and alarm system, creating a possibility that an air bubble may be transferred to a patient, which could then result in a pulmonary air embolism. CareFusion discovered the issue through post-market surveillance of the Alaris systems, according to the warning, which was also noted by Hong Kong regulators.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES